ニュース

FDA requires Covid vaccine makers to expand warning about risk of rare heart inflammation
The US Food and Drug Administration will now require Covid-19 vaccines from Pfizer/BioNTech and Moderna to use expanded ...
Who can get updated COVID vaccines this fall? FDA will OK for high-risk groups, calls for ...
The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at ...
FDA limits access to COVID-19 vaccine to older adults and other high-risk groups – a ...
On May 20, 2025, the Food and Drug Administration announced a new stance on who should receive the COVID-19 vaccine. The ...
Wellbeing Whisper on MSN3 時間
FDA's New Covid-19 Vaccine Strategy Could Leave Millions of Healthy Adults Without Access ...
We have to admit to ourselves that America is deeply divided on the policy issue of repeat COVID-19 vaccine doses or boosters ...
FDA plans to limit COVID shots to those over 65 or with high-risk conditions
Previously, updated COVID vaccines had been recommended annually by the CDC for everyone over the age of 6 months. The CDC has historically set vaccine recommendations, while the FDA determines which ...
FDA Announces Major Overhaul of COVID-19 Vaccine Strategy
The U.S. Food and Drug Administration (FDA) is changing the game on COVID-19 vaccines. Instead of approving yearly boosters ...
FDA’s new approach raises questions about fall COVID vaccine availability
Health experts say there are legitimate questions about how much everyone still benefits from yearly COVID vaccination or ...
Trump FDA overhauls COVID-19 vaccine approval to focus on older populations, high-risk ...
The FDA announced a policy shift for COVID-19 vaccine approvals to focus on Americans considered high-risk of contracting the ...
FDA Changes May Limit COVID Vaccine Access—Drawing Some Criticism. Here’s What We Know
The change marks a shift in the Food and Drug Administration’s policy on approving COVID-19 vaccines, which the new ...
Infectious Disease Advisor19 時間
FDA Approves Novavax’s COVID-19 Vaccine Nuvaxovid
The FDA has approved Nuvaxovid to prevent COVID-19 in adults 65 years and older and high-risk individuals 12 through 64 years ...
FDA approves Novavax COVID vaccine with new conditions
President Donald Trump's tax cut and spending bill faces a critical stress test on Wednesday as Republicans in the U.S. House ...
'Taking away vaccine': No Covid jab for healthy adults in US? FDA to limit vaccine to 65 ...
Under the new approach, updated Covid-19 vaccines are likely to be available this autumn only for people aged 65 and older, ...